Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer.

Gharibo M, Patrick-Miller L, Zheng L, Guensch L, Juvidian P, Poplin E. A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer. Pancreas. 2008 May; 36(4):341-5.

View in: PubMed